Ultrasound-activatable doxorubicin (DOX)-Fe(VI)@HMS-HE-PEG (DFHHP) nanoparticles synergistically boosted the growth suppression of hypoxic osteosarcoma by inducing ferroptosis with notable GPX4 downregulation (51). Here, GPX4 is linked to osteosarcoma.